Basel Medical Group closes registered direct offering, raises gross proceeds of US$7.98 million
Basel Medical Group closed a registered direct offering of 6,000,000 units for gross proceeds of US$7.98 million. Units priced at US$1.33 each, consisting of one ordinary share and one Common Warrant to buy one ordinary share. Net proceeds estimated at about US$7.28 million; funds earmarked for working capital, M&A, an